QT
JAZZ icon

Quantamental Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History

Quantamental Technologies’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,514
Closed -$858K – 485
2022
Q1 		$858K Buy
+5,514
New +$800K 0.5% 45
2020
Q1 		– Sell
-3,907
Closed -$583K – 260
2019
Q4 		$583K Buy
3,907
+1,129
+41% +$154K 0.3% 97
2019
Q3 		$356K Buy
2,778
+689
+33% +$92.4K 0.12% 281
2019
Q2 		$298K Sell
2,089
-490
-19% -$65.9K 0.11% 301
2019
Q1 		$369K Buy
2,579
+1,077
+72% +$140K 0.17% 177
2018
Q4 		$186K Buy
+1,502
New +$223K 0.11% 322

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Quantamental Technologies's JAZZ Position: Q2 2022 in Review

Quantamental Technologies sold out of Jazz Pharmaceuticals (JAZZ) in Q2 2022, closing a stake of 5,514 shares — an estimated $858K sold.

Quantamental Technologies first reported a position in JAZZ in Q4 2018 and held it in 6 quarters. The position peaked at $858K in Q1 2022. 468 funds tracked by Wall St. Rank hold JAZZ as of Q2 2022.

  • Quantamental Technologies reported no remaining Jazz Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Quantamental Technologies sold 5,514 Jazz Pharmaceuticals shares in Q2 2022, an estimated $858K.
  • Quantamental Technologies first reported a position in Jazz Pharmaceuticals in Q4 2018 and held it in 6 quarters.
  • Quantamental Technologies's Jazz Pharmaceuticals position peaked at $858K in Q1 2022.
  • 468 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2022.

Based on Quantamental Technologies's 13F filing for Q2 2022, filed 15 Aug 2022.